The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatology international Ročník 14; číslo 6; s. 889 - 919
Hlavní autoři: Eslam, Mohammed, Sarin, Shiv K., Wong, Vincent Wai-Sun, Fan, Jian-Gao, Kawaguchi, Takumi, Ahn, Sang Hoon, Zheng, Ming-Hua, Shiha, Gamal, Yilmaz, Yusuf, Gani, Rino, Alam, Shahinul, Dan, Yock Young, Kao, Jia-Horng, Hamid, Saeed, Cua, Ian Homer, Chan, Wah-Kheong, Payawal, Diana, Tan, Soek-Siam, Tanwandee, Tawesak, Adams, Leon A., Kumar, Manoj, Omata, Masao, George, Jacob
Médium: Journal Article
Jazyk:angličtina
Vydáno: New Delhi Springer India 01.12.2020
Springer Nature B.V
Témata:
Clinical decision making
Clinical medicine
Clinical practice guidelines
Colorectal Surgery
Decision making
Diagnosis
Epidemiology
Fatty liver
Guidelines
Hepatology
Liver
Liver diseases
Medical diagnosis
Medicine
Medicine & Public Health
Metabolism
Surgery
ISSN:1936-0533, 1936-0541, 1936-0541
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on MAFLD. The guidelines cover various aspects of MAFLD including its epidemiology, diagnosis, screening, assessment, and treatment. The document is intended for practical use and for setting the stage for advancing clinical practice, knowledge, and research of MAFLD in adults, with specific reference to special groups as necessary. The guidelines also seek to improve patient care and awareness of the disease and assist stakeholders in the decision-making process by providing evidence-based data. The guidelines take into consideration the burden of clinical management for the healthcare sector.
Bibliografie:SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
content type line 23
ISSN:1936-0533
1936-0541
1936-0541
DOI:10.1007/s12072-020-10094-2